Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy
| Autor: | Wong, Boaz, Bergeron, Anabel, Maznyi, Glib, Ng, Kristy, Jirovec, Anna, Birdi, Harsimrat K., Serrano, Daniel, Spinelli, Marcus, Thomson, Max, Taha, Zaid, Alwithenani, Akram, Chen, Andrew, Lorimer, Ian, Vanderhyden, Barbara, Arulanandam, Rozanne, Diallo, Jean-Simon |
|---|---|
| Zdroj: | In Molecular Therapy 1 November 2023 31(11):3176-3192 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|